June 2026
The global biopharmaceutical CMO and CRO market size was valued at USD 41.07 billion in 2025 and is expected to hit around USD 76.63 billion by 2035, growing at a CAGR of 6.44%.
May 2026
The global biopharma analytics market is expanding as companies adopt data-driven tools to accelerate drug discovery and clinical development.
January 2026
The global biopharmaceutical third party logistics market size was valued at USD 152.89 billion in 2025 and is expected to hit around USD 287.89 billion by 2035, growing at a CAGR of 6.53%
January 2026
The global biopharmaceuticals market size was valued at USD 537.54 billion in 2025 and is projected to hit around USD 1,983.73 billion by 2035 with a CAGR of 13.95%.
September 2025
The global biopharmaceutical packaging market size was evaluated at USD 95.35 billion in 2024 and is predicted to hit around USD 179.66 billion by 2034, growing at a CAGR of 6.54%.
July 2025
The biopharma clinical trials market is growing with advances in decentralized trials, patient-centric models, and breakthrough therapeutic research.
January 2026
The global artificial intelligence (AI) in biopharmaceutical market size is projected to hit around USD 29.78 billion by 2035 from USD 1.99 billion in 2025 with a CAGR of 31.07%.
August 2025
The next-generation RNA therapeutics market is growing with innovations in RNA-based drugs, improving treatments for cancer, genetic diseases, and infectious conditions.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
August 2025
The global HT supplement (50X) market size was evaluated at USD 1.85 billion in 2024 and is predicted to hit around USD 4.55 billion by 2034, growing at a CAGR of 9.42%.
July 2025
The global red biotechnology market size was evaluated at USD 405.84 billion in 2024 and is predicted to hit around USD 680.7 billion by 2034 with a CAGR of 5.3%.
July 2025
The biological buffers market size is projected to surge around USD 1,653.55 million by 2034 from USD 805.73 million in 2024, with a notable CAGR of 7.45%.
July 2025
The global enzyme inhibitor market size is estimated to hit around USD 45.72 billion by 2034 increasing from USD 27.02 billion in 2024, with a CAGR of 5.40%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com